Traws Pharma, Inc.
TRAW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001130598
No open-market purchases or sales by Traws Pharma, Inc. insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $5.19M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Traws Pharma, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 12 | 19 | +7 |
| Shares | 646.4K | 1.17M | +524.0K (+81.1%) |
| Value | $3.80M | $10.2M | +$6.45M (+169.7%) |
New holders (9)
Institutions that held Traws Pharma, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Perceptive Advisors LLC | 164,157 | $1.46M | 0.04% |
| Alyeska Investment Group, L.P. | 116,714 | $1.04M | 0.00% |
| Ikarian Capital, LLC | 98,493 | $874.6K | 0.25% |
| Vestal Point Capital, LP | 75,000 | $666.0K | 0.04% |
| Geode Capital Management, LLC | 20,801 | $184.7K | 0.00% |
| Boothbay Fund Management, LLC | 28,431 | $108.2K | 0.00% |
| Renaissance Technologies LLC | 10,052 | $89.3K | 0.00% |
| Millennium Management LLC | 10,012 | $88.9K | 0.00% |
| SBI Securities Co., Ltd. | 155 | $1.38K | 0.00% |
Sold out (2)
Institutions that held Traws Pharma, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Tower Research Capital LLC (TRC) | 379 | $2.23K |
| Danske Bank A/S | 7 | $41 |